Periodontal regeneration using strontium-loaded mesoporous bioactive glass scaffolds in osteoporotic rats

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Zhang, Yufeng ^a   Wei, Lingfei ^a   Wu, Chengtie ^b   Miron, Richard J ^a,c  

^a WUHAN UNIVERSITY   (China)

^b SHANGHAI INSTITUTE OF CERAMICS   (China)

^c UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIAL; GLASS; STRONTIUM;

ANIMAL; BIOPSY; BONE DEVELOPMENT; BONE REGENERATION; CHEMISTRY; DISEASE MODEL; FEMALE; IMMUNOHISTOCHEMISTRY; MICRO-COMPUTED TOMOGRAPHY; OSTEOPOROSIS; PERIODONTIUM; POROSITY; RAT; TISSUE SCAFFOLD;

ANIMALS; BIOCOMPATIBLE MATERIALS; BIOPSY; BONE REGENERATION; DISEASE MODELS, ANIMAL; FEMALE; GLASS; IMMUNOHISTOCHEMISTRY; OSTEOGENESIS; OSTEOPOROSIS; PERIODONTIUM; POROSITY; RATS; STRONTIUM; TISSUE SCAFFOLDS; X-RAY MICROTOMOGRAPHY;

EID: 84905924753     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0104527     Document Type: Article

References (52)

1. Genant HK, Cooper C, Poor G, Reid I, Ehrlich G, et al. (1999) Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis. Osteoporos Int 10: 259-264. (Pubitemid 29476187)
2. Tontonoz P, Pei LM (2004) Fat's loss is bone's gain. Journal of Clinical Investigation 113: 805-806. (Pubitemid 38544136)
3. Rodan GA, Martin TJ (2000) Therapeutic approaches to bone diseases. Science 289: 1508-1514.
4. Silva BC, Bilezikian JP (2011) New approaches to the treatment of osteoporosis. Annu Rev Med 62: 307-322.
5. Boonen S, Ferrari S, Miller PD, Eriksen EF, Sambrook PN, et al. (2012) Postmenopausal osteoporosis treatment with antiresorptives: effects of discontinuation or long-term continuation on bone turnover and fracture risk-a perspective. J Bone Miner Res 27: 963-974.
6. Passos Jde S, Gomes-Filho IS, Vianna MI, da Cruz SS, Barreto ML, et al. (2010) Outcome measurements in studies on the association between osteoporosis and periodontal disease. J Periodontol 81: 1773-1780.
7. Sultan N, Rao J (2011) Association between periodontal disease and bone mineral density in postmenopausal women: a cross sectional study. Med Oral Patol Oral Cir Bucal 16: e440-447.
8. von Wowern N, Klausen B, Kollerup G (1994) Osteoporosis: a risk factor in periodontal disease. J Periodontol 65: 1134-1138.
9. Chung CJ, Long HY (2011) Systematic strontium substitution in hydroxyapatite coatings on titanium via micro-arc treatment and their osteoblast/osteoclast responses. Acta Biomater 7: 4081-4087.
10. Hao J, Acharya A, Chen K, Chou J, Kasugai S, et al. (2013) Novel bioresorbable strontium hydroxyapatite membrane for guided bone regeneration. Clin Oral Implants Res.
11. Gallacher SJ, Dixon T (2010) Impact of treatments for postmenopausal osteoporosis (bisphosphonates, parathyroid hormone, strontium ranelate, and denosumab) on bone quality: a systematic review. Calcif Tissue Int 87: 469-484.
12. Marie PJ (2010) Strontium ranelate in osteoporosis and beyond: identifying molecular targets in bone cell biology. Mol Interv 10: 305-312.
13. Mentaverri R, Brazier M, Kamel S, Fardellone P (2012) Potential anti-catabolic and anabolic properties of strontium ranelate. Curr Mol Pharmacol 5: 189-194.
14. Rizzoli R, Reginster JY (2011) Adverse drug reactions to osteoporosis treatments. Expert Rev Clin Pharmacol 4: 593-604.
15. Marie PJ, Ammann P, Boivin G, Rey C (2001) Mechanisms of action and therapeutic potential of strontium in bone. Calcif Tissue Int 69: 121-129. (Pubitemid 32912229)
16. Verberckmoes SC, De Broe ME, D'Haese PC (2003) Dose-dependent effects of strontium on osteoblast function and mineralization. Kidney Int 64: 534-543. (Pubitemid 36871924)
17. Qiu K, Zhao XJ, Wan CX, Zhao CS, Chen YW (2006) Effect of strontium ions on the growth of ROS17/2.8 cells on porous calcium polyphosphate scaffolds. Biomaterials 27: 1277-1286. (Pubitemid 41739552)
18. Peng S, Liu XS, Zhou G, Li Z, Luk KD, et al. (2011) Osteoprotegerin deficiency attenuates strontium-mediated inhibition of osteoclastogenesis and bone resorption. J Bone Miner Res 26: 1272-1282.
19. Choudhary S, Halbout P, Alander C, Raisz L, Pilbeam C (2007) Strontium ranelate promotes osteoblastic differentiation and mineralization of murine bone marrow stromal cells: involvement of prostaglandins. J Bone Miner Res 22: 1002-1010. (Pubitemid 351339722)
20. Blake GM, Compston JE, Fogelman I (2009) Could strontium ranelate have a synergistic role in the treatment of osteoporosis? J Bone Miner Res 24: 1354-1357.
21. Meunier PJ, Slosman DO, Delmas PD, Sebert JL, Brandi ML, et al. (2002) Strontium ranelate: dose-dependent effects in established postmenopausal vertebral osteoporosis-a 2-year randomized placebo controlled trial. J Clin Endocrinol Metab 87: 2060-2066. (Pubitemid 34521489)
22. Meunier PJ, Roux C, Seeman E, Ortolani S, Badurski JE, et al. (2004) The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med 350: 459-468. (Pubitemid 38133766)
23. Reginster JY, Seeman E, De Vernejoul MC, Adami S, Compston J, et al. (2005) Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study. J Clin Endocrinol Metab 90: 2816-2822. (Pubitemid 40686329)
24. Seeman E, Devogelaer JP, Lorenc R, Spector T, Brixen K, et al. (2008) Strontium ranelate reduces the risk of vertebral fractures in patients with osteopenia. J Bone Miner Res 23: 433-438. (Pubitemid 351304674)
25. Ammann P, Badoud I, Barraud S, Dayer R, Rizzoli R (2007) Strontium ranelate treatment improves trabecular and cortical intrinsic bone tissue quality, a determinant of bone strength. J Bone Miner Res 22: 1419-1425. (Pubitemid 351339686)
26. Yan X, Huang X, Yu C, Deng H, Wang Y, et al. (2006) The in-vitro bioactivity of mesoporous bioactive glasses. Biomaterials 27: 3396-3403.
27. Li X, Shi J, Dong X, Zhang L, Zeng H (2008) A mesoporous bioactive glass/polycaprolactone composite scaffold and its bioactivity behavior. J Biomed Mater Res A 84: 84-91. (Pubitemid 350244249)
28. Wu C, Ramaswamy Y, Zhu Y, Zheng R, Appleyard R, et al. (2009) The effect of mesoporous bioactive glass on the physiochemical, biological and drug-release properties of poly(DL-lactide-co-glycolide) films. Biomaterials 30: 2199-2208.
29. Wu C, Zhang Y, Zhou Y, Fan W, Xiao Y (2011) A comparative study of mesoporous glass/silk and non-mesoporous glass/silk scaffolds: physiochemistry and in vivo osteogenesis. Acta Biomater 7: 2229-2236.
30. Wei L, Ke J, Prasadam I, Miron RJ, Lin S, et al. (2014) A comparative study of Sr-incorporated mesoporous bioactive glass scaffolds for regeneration of osteopenic bone defects. Osteoporos Int.
31. Zhang Y, Wei L, Chang J, Miron RJ, Shi B, et al. (2013) Strontium-incorporated mesoporous bioactive glass scaffolds stimulating in vitro proliferation and differentiation of bone marrow stromal cells and in vivo regeneration of osteoporotic bone defects. Journal of Materials Chemistry B 1: 5711-5722.
32. Cheng N, Dai J, Cheng X, Li S, Miron RJ, et al. (2013) Porous CaP/silk composite scaffolds to repair femur defects in an osteoporotic model. J Mater Sci Mater Med 24: 1963-1975.
33. Zhang Y, Cheng N, Miron R, Shi B, Cheng X (2012) Delivery of PDGF-B and BMP-7 by mesoporous bioglass/silk fibrin scaffolds for the repair of osteoporotic defects. Biomaterials 33: 6698-6708.
34. Miron RJ, Wei L, Yang S, Caluseru OM, Sculean A, et al. (2014) Effect of an Enamel Matrix Derivative on Periodontal Wound Healing/Regeneration in an Osteoporotic Model. J Periodontol: 1-12.
35. Wu C, Zhou Y, Lin C, Chang J, Xiao Y (2012) Strontium-containing mesoporous bioactive glass scaffolds with improved osteogenic/cementogenic differentiation of periodontal ligament cells for periodontal tissue engineering. Acta Biomater 8: 3805-3815.
36. Zhao M, Jin Q, Berry JE, Nociti FH, Jr., Giannobile WV, et al. (2004) Cementoblast delivery for periodontal tissue engineering. J Periodontol 75: 154-161. (Pubitemid 38312780)
37. Chattopadhyay N, Quinn SJ, Kifor O, Ye C, Brown EM (2007) The calcium-sensing receptor (CaR) is involved in strontium ranelate-induced osteoblast proliferation. Biochem Pharmacol 74: 438-447. (Pubitemid 46970843)
38. Han L, Okiji T (2011) Evaluation of the ions release / incorporation of the prototype S-PRG filler-containing endodontic sealer. Dent Mater J.
39. Sakai A, Valanezahad A, Ozaki M, Ishikawa K, Matsuya S (2012) Preparation of Sr-containing carbonate apatite as a bone substitute and its properties. Dent Mater J 31: 197-205.
40. Bonnelye E, Chabadel A, Saltel F, Jurdic P (2008) Dual effect of strontium ranelate: stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption in vitro. Bone 42: 129-138. (Pubitemid 350297175)
41. Caudrillier A, Hurtel-Lemaire AS, Wattel A, Cournarie F, Godin C, et al. (2010) Strontium ranelate decreases receptor activator of nuclear factor-KappaB ligand-induced osteoclastic differentiation in vitro: involvement of the calciumsensing receptor. Mol Pharmacol 78: 569-576.
42. Peng S, Liu XS, Huang S, Li Z, Pan H, et al. (2011) The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin. Bone 49: 1290-1298.
43. Roy M, Bose S (2012) Osteoclastogenesis and osteoclastic resorption of tricalcium phosphate: effect of strontium and magnesium doping. J Biomed Mater Res A 100: 2450-2461.
44. Yamaguchi M, Weitzmann MN (2012) The intact strontium ranelate complex stimulates osteoblastogenesis and suppresses osteoclastogenesis by antagonizing NF-kappaB activation. Mol Cell Biochem 359: 399-407.
45. Baier M, Staudt P, Klein R, Sommer U, Wenz R, et al. (2013) Strontium enhances osseointegration of calcium phosphate cement: a histomorphometric pilot study in ovariectomized rats. J Orthop Surg Res 8: 16.
46. Mohan BG, Shenoy SJ, Babu SS, Varma HK, John A (2013) Strontium calcium phosphate for the repair of leporine (Oryctolagus cuniculus) ulna segmental defect. J Biomed Mater Res A 101: 261-271.
47. Andersen OZ, Offermanns V, Sillassen M, Almtoft KP, Andersen IH, et al. (2013) Accelerated bone ingrowth by local delivery of strontium from surface functionalized titanium implants. Biomaterials 34: 5883-5890.
48. Lopa S, Mercuri D, Colombini A, De Conti G, Segatti F, et al. (2013) Orthopedic bioactive implants: Hydrogel enrichment of macroporous titanium for the delivery of mesenchymal stem cells and strontium. J Biomed Mater Res A.
49. Yang GL, Song LN, Jiang QH, Wang XX, Zhao SF, et al. (2012) Effect of strontium-substituted nanohydroxyapatite coating of porous implant surfaces on implant osseointegration in a rabbit model. Int J Oral Maxillofac Implants 27: 1332-1339.
50. Berglund IS, Brar HS, Dolgova N, Acharya AP, Keselowsky BG, et al. (2012) Synthesis and characterization of Mg-Ca-Sr alloys for biodegradable orthopedic implant applications. J Biomed Mater Res B Appl Biomater 100: 1524-1534.
51. Fu DL, Jiang QH, He FM, Yang GL, Liu L (2012) Fluorescence microscopic analysis of bone osseointegration of strontium-substituted hydroxyapatite implants. J Zhejiang Univ Sci B 13: 364-371.
52. Brauer DS, Karpukhina N, Kedia G, Bhat A, Law RV, et al. (2012) Bactericidal strontium-releasing injectable bone cements based on bioactive glasses. J R Soc Interface.